Imiquimod attenuates airway inflammation and decreases the expression of thymus and activation regulated chemokine in allergic asthmatic mice.
Jin
Shu-xian
SX
Respiratory Department of Internal Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Yin
Kai-sheng
KS
Bian
Tao
T
Sun
Pei-li
PL
D000634:Aminoquinolines / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002452:Cell Count; D054414:Chemokine CCL17; D054422:Chemokine CCL22; D019742:Chemokines, CC / Q000032:analysis* / Q000235:genetics; D016207:Cytokines / Q000096:biosynthesis; D005434:Flow Cytometry; D000077271:Imiquimod; D015847:Interleukin-4 / Q000037:antagonists & inhibitors; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D012333:RNA, Messenger / Q000032:analysis; D050800:STAT6 Transcription Factor / Q000032:analysis / Q000037:antagonists & inhibitors / Q000235:genetics; D015398:Signal Transduction / Q000187:drug effects
D000634:Aminoquinolines; C499538:Ccl17 protein, mouse; C515483:Ccl22 protein, mouse; D054414:Chemokine CCL17; D054422:Chemokine CCL22; D019742:Chemokines, CC; D016207:Cytokines; D012333:RNA, Messenger; D050800:STAT6 Transcription Factor; D015847:Interleukin-4; D000077271:Imiquimod